Expert Advice

Geographic atrophy is an advanced form of dry age-related macular degeneration (AMD), in which cells in the retina waste away, causing vision loss.

Currently, many patients with wet age-related macular degeneration (AMD) require monthly injections into the eye to preserve their vision. Those with advanced dry AMD, also called geographic atrophy (GA), have no effective treatments available to them. Fortunately, AMD research and drug developments are advancing rapidly to bring patients better treatments.

Learn about the potential for cell transplantation for the treatment of the advanced form of dry age-related macular degeneration, with some very important information about clinical trials.

Read about the exciting new research for treatment of dry age-related macular degeneration.

Learn about a clinical trial that may slow the progression of advanced dry age-related macular degeneration.

New treatments for the advanced form of dry age-related macular degeneration (AMD) are on the horizon. Learn about these new experimental drugs; novel mechanisms that are actively being studied regarding the development of macular degeneration; and helpful suggestions that might decrease your risk of progression to the late stage of this eye disease.

Age-related macular degeneration (AMD) is caused by a number of genetic and environmental factors. People with an affected parent have approximately twice the risk of getting the disease than someone whose parents do not have AMD. Learn about the genes that increase the risk of AMD, and whether genetic testing is recommended.

Learn about the different types of retinal imaging techniques eye doctors use to diagnose and treat AMD, including retinal fundus photos, OCT, AO-SLO, and more.

Learn about a number of procedures and surgeries that are currently available or are in clinical trials for patients with advanced age-related macular degeneration.